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Late-onset epilepsy (LOE) ﬁrst occurs after 60 years of age and may be due to occult cerebrovascular disease (CVD) which confers
an increased risk of stroke. However, patients with late-onset epilepsy are not currently consistently investigated or treated for
cerebrovascular risk factors. We discuss how abnormalities of neurovascular unit function, namely, changes in regional cerebral
blood ﬂow and blood brain barrier disruption, may be caused by occult cerebrovascular disease but present clinically as late-onset
epilepsy. We describe novel magnetic resonance imaging methods to detect abnormal neurovascular unit function in subjects with
LOE and controls. We hypothesise that occult CVD may cause LOE as a result of neurovascular unit dysfunction.
1.Introduction
Late-onset epilepsy (LOE) is deﬁned as epilepsy that ﬁrst
occurs after 60 years of age, and is considered by family
d o c t o r st ob er a r e[ 1], despite the fact that it accounts for
over a third of all incident epilepsy [2]. LOE occurs in
approximately 4% of stroke patients [3], but importantly,
LOE can present without a history of overt cerebrovascular
disease (CVD), yet LOE confers a subsequent threefold
increased risk of stroke [4]. It is widely assumed that LOE
is often attributable to otherwise occult CVD. However, at
least in the UK, patients with LOE tend to be prescribed
anticonvulsant medication, but the opportunity that LOE
presents as a marker of increased stroke risk may be lost if a
presentation of LOE does not prompt clinicians to screen for
other vascular risk factors and initiate appropriate vascular
secondary prevention measures, for which there is a strong
case [4, 5].
Occult CVD may be detected on brain imaging but by
deﬁnition does not manifest otherwise clinically. Structural
imaging markers of occult CVD are thought to include
corticalorsubcorticalinfarcts,whitematterhyperintensities,
leukoaraiosis (LA), cerebral atrophy, and brain microb-
leeds (BMBs) which are a marker particularly of cerebral
microangiopathy, and strongly associated with hypertension
[6]. However, between 72 and 94% of occult infarcts are
subcortical, yet epilepsy derives from the cortex. If occult
CVD is aetiologically important in LOE then markers of
CVD would be expected to have a more diﬀuse anatomical
distribution than described previously. Subcortical lesions
in isolation would not be expected to cause the disruption
of corticocortical or subcorticocortical circuits that would
be a necessary substrate for epileptogenesis. Markers of
functional rather than structural integrity may then be
necessary to resolve this apparent discrepancy. For example,
a corollary is seen in patients with frontal lobe cognitive
dysfunction where structural lesions on MRI are conﬁned
anatomically to subcortical regions. In this group, frontal
lobe hypometabolism measured using FDG-PET correlated
with subcortical lacunes and white matter lesions [7]. We
hypothesisethatoccultCVDmaycauseLOEvianeurovascu-
lar unit dysfunction, namely, producing changes in cerebral
blood ﬂow (CBF) and/or disruption of the blood brain
barrier (BBB). We present evidence for and against this2 Cardiovascular Psychiatry and Neurology
hypothesis and describe novel MRI methods for detecting
neurovascular unit dysfunction in subjects with LOE and
control participants.
2.TheNeurovascularUnitand
NeurovascularCoupling
Thestructuralandfunctionalintegrityofthecentralnervous
system depends on coupling between neural activity and
(CBF), and regulation of transport across the (BBB). These
two critical processes rely on the coordinated activity of a
“neurovascular unit” comprising the cerebral endothelium,
neurones, and glial cells. In the normal healthy state the
increase in CBF produced by brain activity, termed func-
tional hyperaemia, is an example of the close interaction
between the neurones, glia, and vascular cells. Neurovascular
coupling (NVC) can be deﬁned as the relationship between
the neural response which can be measured by a variety of
methodsandtheassociatedvascularresponse,thatis,change
in CBF.
3.Assessing NeurovascularUnitFunction
Functional MRI can help assess the functional capacity of
cerebral blood vessels to respond to neuronal activation
[8], using the Blood Oxygen Level Dependent (BOLD)
signal. However, the BOLD signal is physiologically complex,
depending on the relative change in CBF and oxygen
metabolism (CMRO2). A relatively new technique using
simultaneous arterial spin labelling (ASL) and BOLD allows
quantiﬁcation of these component parts.
ASL provides a quantitative measurement of CBF [9].
T h eB O L Ds i g n a li ss e n s i t i v et od e o x y h a e m o g l o b i na n d
is dependent on changes to CBF and CMRO2, which
both change during neuronal activity [10]. A calibrating
procedure is employed, which may consist of asking patients
to hold their breath to induce hypercapnia (excess carbon
dioxide in the blood). This causes CBF to increase and it is
assumed that CMRO2 does not change, so isolating the CBF
component of the BOLD signal. Using simultaneous BOLD
and ASL imaging allows the calculation of a calibration
factor which relates BOLD signal change to changes in
CBF [8]. Patients then perform a task which increases
cortical neuronal activity and oxygen demand. CBF change
is measured using ASL again, and the calculated calibration
factor enables CMRO2 to be calculated from the BOLD
signal change [8]. Measurements of CBF can then be
comparedwithCMRO2duringthetask.Itmaybepossibleto
see that CMRO2 becomes uncoupled from CBF which may
indicate that the blood vessels cannot deliver the increases
in blood ﬂow required. This reduction in functional capacity
may suggest occult ischaemia.
Studies show an association between reduced regional
CBF (rCBF) and occult infarcts. In a study of 246 clinically
neurologically normal patients, 32 (13.0%) patients were
found to have occult lacunar infarcts. Of the 34 patients aged
over60,7(20.6%)werefoundtohaveoccultlacunarinfarcts.
Patients with occult lacunar infarcts have signiﬁcantly
reduced rCBF in both right and left frontotemporal regions
compared to patients without occult lacunar infarcts
(P<. 05) [11]. Furthermore nine patients (mean age
63.4, range 58–67) with occult infarcts were found to have
reduced rCBF in all cortices (signiﬁcant in the temporal and
parietal cortices, P<. 05) and a nonsigniﬁcant reduction in
rCMRO2 globally compared to nine controls without occult
infarcts, however, patients with epilepsy were not speciﬁcally
excluded [12]. These ﬁndings suggest a diﬀuse vascular
encephalopathy, which may result in a reduced functional
capacity of the blood vessels and subsequent ischaemia.
PatientswithbothLOEandLAhavesigniﬁcantlyreduced
regional CMRO2 (rCMRO2) in all cortices (frontal, tempo-
ral, parietal, and occipital) compared to controls, indicating
hypometabolism in these regions (P<. 05) [13]. These
patients also have signiﬁcantly reduced rCBF in all cortices
compared to controls (P<. 05) [13]. However, these results
m a yh a v eb e e nc o n f o u n d e da sn om e a s u r eo fc a r o t i da r t e r y
stenosis was made, which aﬀects CBF measurements [14].
Reduced rCBF and rCMRO2 may indicate either a degen-
erative or vascular underlying process [13]. If the cortical
neurones are degenerating their demand for oxygen reduces
resultinginhypometabolismandreducedbloodﬂow.Onthe
other hand, damage to cortical blood vessels may result in
reduced blood ﬂow, therefore reducing oxygen delivery to
the tissues and inducing hypometabolism. Both vascular and
degenerative processes may be present in older patients.
4. A PreliminaryInvestigationof
NeurovascularCoupling inPatientswith
Late-OnsetEpilepsy
With relevant ethical and research governance approvals,
we undertook an initial pilot clinical study in subjects with
LOE and conventional vascular risk factors (aged 60 or
over at onset, with at least 2 seizures of presumed partial
onset), and control subjects with (RF+) or without (RF−)
vascular risk factors. We excluded subjects with a history
of clinically overt transient ischaemic attack or stroke, focal
motororsensorysigns,knownaetiologyforepilepsyoracute
symptomatic seizures, cognitive dysfunction suﬃcient to
interfere with daily activities, or any other active, signiﬁcant
medical condition likely to complicate assessment.
Six participants were scanned using a 3T MRI scanner
(Siemens Trio, Erlangen, Germany). The body coil was used
for signal transmission and an 8−channel phased array
head coil was used for signal collection. The MRI protocol
comprised precerebral extracranial and intracranial time of
ﬂight angiography, high resolution T1 and T2 weighted
images, T2∗ and ﬂuid attenuated inversion recovery (FLAIR)
anatomic images, and a pulsed arterial spin labelling (ASL)
sequence (Q2TIPS). Simultaneous blood oxygenation level
dependent(BOLD)contrastfunctionalMRI(fMRI)wasalso
performed, with the participant performing a breath-hold
paradigm (6 cycles of breath holding on inspiration for 15s
followedbynormalbreathingfor40s)andacombinedvisual
and motor paradigm (8 cycles of bilateral hand squeezing of
foam pads for 20s followed by 20s rest, cued with a ﬂashingCardiovascular Psychiatry and Neurology 3
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Figure 1: Regions of activation for the combined motor and visual task in a healthy volunteer, presented at a false detection rate of P<. 05.
visual display). Custom written MATLAB programs (The
MathWorks Inc., MA) were used to generate CBF and BOLD
images using an appropriate kinetic model [9]. Standard
analysis within BrainVoyager was used to identify regions
that were signiﬁcantly active (false detection rate P<. 05)
during the combined visual and motor task (Figure 1). CBF
and BOLD time courses during both the motor task and
breath hold were recorded within these regions using the
model previously described [8].
Data were available for 3 subjects with LOE, and 3
controls (1 RF+, 2 RF−). 1 patient and 1 control (RF+)
had mild white matter hyperintensities; all LOE subjects and
1 control (RF+) had reduced cortical volume compared to
the other 2 controls (RF−); no other structural lesions were
identiﬁed. Only one participant had extracranial or intracra-
nial stenosis (RF+ control, 40% stenosis at origin of right
internal carotid artery). Average whole brain (mean 35.5mL
blood/min/100g tissue, range 30.3 to 39.3), grey matter
(mean 49.6, range 42.6 to 55.3) and white matter (mean
21.0) perfusion was similar across all participants. During
the combined visual and motor task, all subjects showed
signiﬁcant activation in the visual cortex, whereas motor
cortex activation was more variable, presumably due to
diﬀerentperformancelevelsonthetask.Therefore,responses
were recorded from the visual cortex only. BOLD and CBF
responses to breath hold were very variable, to the extent
that they could not be used reliably to calibrate the BOLD
signal during activation. Future work should consider the
use of gas-induced hypercapnia [15]o rh y p e r o x i a[ 16, 17]
for calibration as, while they are more diﬃcult to administer,
they are better controlled than breath hold [18]. The BOLD
and CBF responses showed diﬀerences in timing between the
groups, with the RF+ control and the LOE subjects showing
a later peak in the BOLD response compared to RF−controls
(Figure 2). The ﬁnding of reduced cortical volumes among
LOE subjects and the RF+ control compared to RF−controls
probably reﬂects otherwise occult cerebrovascular disease
given these participants’ vascular risk factor burden.
This initial work demonstrates the feasibility of simulta-
neous ASL perfusion and BOLD measures in LOE patients,
albeit with limited interpretation possible in this pilot study.
Further work will be needed to explore potential impairment
ofNVCinLOEinadditiontotheapparentstructuralchanges
probably attributable to otherwise occult cerebrovascular
disease.
5.NeurovascularCoupling andEpilepsy
Epilepsy is an abnormal state which places supranormal
demands on the cerebral autoregulatory mechanisms con-
sequent upon an enormous increase in CMRO2 following
interictal and ictal events [19]. Normal NVC mechanisms4 Cardiovascular Psychiatry and Neurology
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Figure 2: BOLD (a) and CBF (b) responses in participants’ visual cortices. CBF is measured in mL blood/min/100g tissue. Times are in
seconds from the start of the motor task, that is, visually-cued hand-squeezing began at time 0 and lasted 20seconds, followed by 20seconds
of rest. Error bars represent the standard error over the 8 cycles.
may not be relevant to the epileptic brain. It has been
long debated whether or not CBF is adequate to meet the
increased metabolic demands of epilepsy. Originally, based
on histological similarities between ischaemic and epileptic
braindamage,itwasproposed thatthecelldamagefollowing
status epilepticus was caused by cerebral hypoxia. However,
subsequent work refuted this theory, ﬁnding a greater
increase in CBF relative to CMRO2, that cellular damage
diﬀers between status epilepticus and hypoxic injury, that
seizures induce increases rather than reduction in venous
oxygenation, and evidence of oxidation in the mitochondrial
transport chain, NADH and cytochrome oxidase, increases
in tissue pO2, and evidence of tissue injury in the absence of
hypoxia [19].
6. How Might Loss of NVU Integrity in CVD Be
LinkedtoEpileptogenesis?
Thereareconceivablyseveralmechanismslinking disruption
of NVU integrity—in terms of either an altered relation-
ship between neural activity and CBF, or dysregulation of
transportacrosstheBBB—andepileptogenesisinthecontext
of CVD (Figure 3). Cerebral amyloid angiopathy (CAA), a
neurovascular degenerative disorder resulting in progressive
neurovascular unit dysfunction and in some cases associated
with seizures, is brieﬂy discussed as a potentially useful case
study in this area.
6.1. Changes in CBF. The notion that haemodynamic alter-
ations might localise and predict the onset of seizures is not
new but advances in imaging, including BOLD fMRI, has
refocused attention on this area. Recently, changes in BOLD
signal have been observed to precede scalp EEG epileptic
spikes, raising the possibility that BOLD signal change is
due to an event “invisible” to the scalp EEG, or that an
abrupt haemodynamic change is responsible for the epileptic
discharge [20]. However, whether it is hypoperfusion, hyper-
perfusion, or indeed the transition between the two states
that might theoretically be important is not straightforward
to determine. A study of 40 patients with complex partial
seizures using 133Xe CT imaging at rest and during a light
stimulation procedure found a signiﬁcant increase in rCBF
in the region of the suspected epileptic focus in nonlesional
patients [21]. Middle cerebral artery blood ﬂow velocity
assessed with transcranial Doppler ultrasonography during
simultaneous EEG recording, reveals asymmetric perfusion
increasescloselyrelatedtoonsetandcessationofEEGseizure
activity during simple partial motor seizures [22]. Another
study using perfusion CT to measure rCBF with EEG
correlationfoundincreasedrCBFduringsubtlestatusepilep-
ticus but regional hypoperfusion in postictal patients [23].Cardiovascular Psychiatry and Neurology 5
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Figure 3: Proposed model of epileptogenicity in occult CVD.
The central green/white circle depicts the elements of the healthy
neurovascular unit. The outer red/white circle depicts possible
sequelae of hypertension, a key determinant of CVD. Structural
and functional integrity of the neurovascular unit may be com-
p r o m i s e db yad i ﬀuse cerebral microangiopathy and endothelial
and BBB dysfunction with BBB leakage. Potential mechanisms
leading to epileptogenesis might then include impaired cerebral
perfusion and neurovascular uncoupling, excitotoxicity occurring
as a consequence of ischaemia, or extravasation of serum proteins
and inﬂammation.
Indeed, postictal (or Todd’s) paresis has been found, using
perfusion MRI, to be accompanied by a reversible global
hemispheric hypoperfusion, indicating transient but marked
cerebrovascular dysfunction in postictal paresis [24]. In this
instance, discrimination from emerging stroke is clearly
important to avoid potentially harmful interventions such
as thrombolysis. The occurrence of early onset seizures after
acute ischaemic stroke has been related to the severity of
stroke, with thrombolysis arguably reducing the occurrence
of late-onset seizures after stroke, perhaps through improved
reperfusion of the ischaemic brain regions [25]. Intriguingly,
seizures occurring during thrombolytic therapy for acute
ischaemic stroke and heralding dramatic recovery have been
attributed to cerebral reperfusion and/or hyperperfusion
[26].
An experimental model of stroke-induced epilepsy may
shed light on how reduced rCBF producing ischaemia leads
to LOE. The model uses glutamate excitotoxic injury to
produce an infarct surrounded by an ischaemic penumbra.
The ischaemic neurones survive the glutamate injury and
produce spontaneous recurrent epileptiform discharges [27]
which may be due to their increased basal levels of intracel-
lular calcium [28]. However, this model uses 2-day-old rats
and may not be appropriate for modelling LOE in occult
CVD. An adult animal model of occult CVD is therefore
needed to investigate the mechanisms of epileptogenesis
which may be more applicable to LOE patients.
6.2. BBB Dysfunction. The microvasculature is abnormal in
cerebral small vessel disease (cSVD), with loss of smooth
muscle cells, vessel wall thickening, luminal narrowing, and
increased vessel stiﬀness. These changes may contribute
to the attenuation of vasomotor reactivity in response to
hypercapnia or acetazolamide seen in cSVD [29], and con-
sequently lead to an impairment of NVC. Such impairment
of NVC appears to be speciﬁc for cSVD [30]. Recently
BBB breakdown has received considerable attention as a
cause of cSVD. BBB breakdown may lead to ischaemia, LA
and lacunar infarcts [31]. Mild chronic hypertension may
damagecerebrovascularendotheliuminsmallvesselsleading
tothickeningofthearterialwallandnarrowingofthelumen,
resulting in ischaemia (LA if ischaemia occurs in white
matter)orinfarction.Alternatively,thedamagetothearterial
wall may progress, causing disintegration and a leak of blood
[31]. BBB leak may be visualised as small areas of low signal
on T2∗-weighted MR images which may be deposits of
haemosiderin,abreakdownproductofhaemoglobin,usually
indicating a BMB [32].
Seiﬀert and colleagues created a model of BBB
breakdown-induced epilepsy by perfusing a section of adult
ratsomatosensorycortexwithserum[33].77%ofslicesfrom
treated cortices developed increased excitability compared
to sham-operated controls. As the changes in ﬁring rate
were only evident four days after treatment, the authors
suggest that an accumulation of albumin in the extracellular
space due to BBB leak is required for epileptogenesis. More
recent work suggests that BBB breakdown may lead to
changes in astrocyte gene expression in astrocytes, which
predicts impaired uptake of extracellular potassium [34].
The increased extracellular K+ may facilitate the conduction
of excessive neuronal discharges, resulting in epilepsy [35].
However, the results of these animal experiments may not
be applicable to human patients with epilepsy. Furthermore,
to determine whether BBB breakdown in this model is truly
occult, the motor cortex could be perfused with serum and
the animals’ motor function observed.
Novel MRI techniques to assess BBB opening could
complement functional MRI to oﬀer a fascinating insight
into neurovascular unit function in terms of metabolism,
neurovascular response, and BBB integrity. For example,
there is increasing interest in the use of dynamic contrast-
enhancedMRIinarangeofconditions,includingageingand
cerebralmicrovasculardisease[36].Theprospectofapplying
this technique in patients with LOE is appealing.
6.3. Cerebral Amyloid Angiopathy: A Case Study in Neurovas-
cular Unit Disruption and Epileptogenesis. Cerebral amyloid
angiopathy (CAA) is a disorder caused by the accumulation
of amyloid in cerebral vessels which leads to progressive
dysfunction of the neurovascular unit, failure of vascular
reactivity, smooth muscle cell loss, and eventual breakdown
of vessel integrity [37]. CAA is associated with BMBs
and recurrent lobar intracerebral haemorrhage. It is an
increasingly recognised disorder in the elderly and can6 Cardiovascular Psychiatry and Neurology
be associated with recurrent seizures. Other manifestations
include white matter disease, cortical infarcts, and cognitive
dysfunction. Transient neurological events characterised by
spread of symptoms to contiguous body areas during
episodes, in keeping with seizures, have been described in
CAA [38]. Seizures have also been reported in CAA by other
workers [39]. CAA-associated vascular inﬂammation has
also been described in a subset of CAA patients presenting
with cognitive decline and seizures [40]. Further studies of
neurovascular unit dysfunction in CAA and the potential
relationship with epileptogenesis may prove valuable.
7. Conclusion
Occult CVD may cause LOE via neurovascular unit dysfunc-
tion, namely, producing changes in (CBF) and/or disruption
of the (BBB). We have demonstrated the feasibility of a novel
MRI technique to investigate NVC, reﬂecting underlying
neurovascular unit integrity, in this population. Further
studies will be important given the likely increasing burden
of CVD and its complications in an ageing population.
Increasing recognition of entities such as CAA is likely to
provide further opportunities for research in this area. At the
current time, conventional imaging techniques remain the
mainstay of the identiﬁcation of otherwise occult CVD, and
it is evidence such as this that should prompt screening for
other vascular risk factors and the initiation of appropriate
vascular secondary prevention measures.
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